# Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma

> **NCT01528618** · PHASE3 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 362 (actual)

## Conditions studied

- Nasopharyngeal Neoplasms

## Interventions

- **DRUG:** gemcitabine and cisplatin
- **DRUG:** 5-Fluorouracil and cisplatin

## Key facts

- **NCT ID:** NCT01528618
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02-21
- **Primary completion:** 2016-04-10
- **Final completion:** 2020-12-20
- **Target enrollment:** 362 (ACTUAL)
- **Last updated:** 2021-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01528618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01528618, "Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01528618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*